Thomas Jouary
Centre Hospitalier De Pau · 183 works · 16,701 citations · h-index 39
Top works
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study
- Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo
- Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
- Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
- Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo
- COMBI-d: A randomized, double-blinded, Phase III study comparing the combination of dabrafenib and trametinib to dabrafenib and trametinib placebo as first-line therapy in patients (pts) with unresectable or metastatic BRAFV600E/K mutation-positive cutaneous melanoma
- An update on BREAK-3, a phase III, randomized trial: Dabrafenib (DAB) versus dacarbazine (DTIC) in patients with BRAF V600E-positive mutation metastatic melanoma (MM).
- Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases
- Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre
- The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool
- Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure
- Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): A retrospective case series of 19 patients
- Comprehensive Association Analysis of Candidate Genes for Generalized Vitiligo Supports XBP1, FOXP3, and TSLP
- IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases
- Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non‐segmental vitiligo
- Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms
- Common variants in FOXP1 are associated with generalized vitiligo
- Severe cutaneous adverse reaction associated with vemurafenib: DRESS , AGEP or overlap reaction?